Exosomes and Nanoengineering: A Match Made for Precision Therapeutics

Targeted exosomal delivery systems for precision nanomedicine attract wide interest across areas of molecular cell biology, pharmaceutical sciences, and nanoengineering. Exosomes are naturally derived 50–150 nm nanovesicles that play important roles in cell‐to‐cell and/or cell‐to‐tissue communicatio...

Full description

Saved in:
Bibliographic Details
Published in:Advanced materials (Weinheim) 2020-05, Vol.32 (18), p.e1904040-n/a
Main Authors: Tran, Phuong H. L., Xiang, Dongxi, Tran, Thao T. D., Yin, Wang, Zhang, Yumei, Kong, Lingxue, Chen, Kuisheng, Sun, Miaomiao, Li, Yong, Hou, Yingchun, Zhu, Yimin, Duan, Wei
Format: Article
Language:English
Subjects:
Animals
Antibodies
aptamers
Drug delivery systems
Engineering
Exosomes
Humans
Immune system
Materials science
Nanoengineering
Nanomedicine - methods
Precision Medicine - methods
precision therapeutics
targeting ligands
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Targeted exosomal delivery systems for precision nanomedicine attract wide interest across areas of molecular cell biology, pharmaceutical sciences, and nanoengineering. Exosomes are naturally derived 50–150 nm nanovesicles that play important roles in cell‐to‐cell and/or cell‐to‐tissue communications and cross‐species communication. Exosomes are also a promising class of novel drug delivery vehicles owing to their ability to shield their payload from chemical and enzymatic degradations as well as to evade recognition by and subsequent removal by the immune system. Combined with a new class of affinity ligands known as aptamers or chemical antibodies, molecularly targeted exosomes are poised to become the next generation of smartly engineered nanovesicles for precision medicine. Here, recent advances in targeted exosomal delivery systems engineered by aptamer for future strategies to promote human health using this class of human‐derived nanovesicles are summarized. Recent advances in research and development of aptamer‐guided exosomes as a new nanoengineering strategy to achieve targeted drug delivery using bio‐nanoparticles highlight a promising next generation of targeted drug delivery systems. Cross‐fertilization between areas of exosomes and aptamers in both preclinical translational studies predicts a bright future for aptamer‐guided exosomal delivery in precision nanomedicine.
ISSN:0935-9648
1521-4095
DOI:10.1002/adma.201904040